ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2535

Behçet’s syndrome: distinct features in 344 pediatric and adult patients in a non-endemic region

Ricardo Machado1, Thales Souza2, Matheus França3, Vinicius Matias4, Sylvia Farhat1, Carolina Siqueira4, Maria Carolina Santos4, Lia Steuer1, Luisa Forero1, Rafael Bassara Macedo5, Thiago Freitas6, barbara Bayeh7, Carolina Ejnisman8, Pedro Araujo9, Rafael Cordeiro10, Fabio Specian5, Verena Balbi1, Nadia Emi Aikawa11, Katia Kozu1, Clovis Artur Silva12, Lucia Maria Campos13, Adriana Elias14 and Henrique Giardini6, 1Instituto da Criança e do Adolescente, Hospital das Clinicas, Sao Paulo, Sao Paulo, Brazil, 2Faculdade de Medicina da Universidade de Brasilia, Brasilia, Distrito Federal, Brazil, 3Instituto da Criança e do Adolescente, Hospital das Clinicas, University of Sao Paulo Medical School, Sao Paulo, Sao Paulo, Brazil, 4Faculdade de Ciências Medicas da Santa Casa de Sao Paulo, Sao Paulo, Sao Paulo, Brazil, 5Rheumatology Division, Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil, 6Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil, São Paulo, Brazil, 7Hospital das Clínicas, University of Sao Paulo Medical School, Sao Paulo, Sao Paulo, Brazil, 8Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil, Sao Paulo, Brazil, 9Universidade de São Paulo, Sao Paulo, São Paulo, Brazil, 10Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil, São Paulo, Sao Paulo, Brazil, 11Rheumatology Division and Pediatric Rheumatology Unit, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil, Sao Paulo, São Paulo, Brazil, 12University of São Paulo, São Paulo, São Paulo, Brazil, 13Instituto da Criança e do Adolescente, São Paulo, São Paulo, Brazil, 14Pediatric Rheumatology Unit, Instituto da Criança e do Adolescente, Hospital das Clinicas, University of Sao Paulo Medical School, São Paulo, São Paulo, Brazil

Meeting: ACR Convergence 2025

Keywords: autoimmune diseases, Behçet's Syndrome, Diagnostic criteria, Pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2524–2546) Vasculitis – Non-ANCA-Associated & Related Disorders Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Behçet’s syndrome (BS) is a chronic inflammatory disorder characterized by a heterogeneous clinical presentation, occurring primarily in young adults and very rarely in children and adolescents. In addition, there are few studies that compared childhood-onset BS (cBS) and adult-onset BS (aBS), especially in non-endemic regions. Therefore, the objectives of the present study were to evaluate demographic, clinical and therapeutic data in cBS and aBS.

Methods: Medical records of 344 patients [99 cBS (≤ 18 years-old) and 245 aBS] from three tertiary Brazilian Rheumatology centers were reviewed in order to compare clinical and therapeutic features. cBS and aBS were classified according to International Study Group and/or the International Criteria for Behçet’s Disease.

Results: The median age at diagnosis was 11(0.5-17) years in cBS and 30(18-76) years in aBS. The median follow-up time was significantly reduced in cBS compared to aBD [7(0-23) vs. 10(0-27) years, p=0.014], with similar female sex in both groups (56% vs. 62%, p=0.14). Classification criteria were fulfilled in 82% of cBS and 100% of aBS patients. Fever (30% vs. 15%, p=0.002), gastrointestinal involvement (55% vs. 14%, p=0.003), and a family history of autoimmune diseases (22% vs. 16%, p=0.001) were significantly higher in cBS compared to aBS. In contrast, genital ulcers (67% vs. 81%, p=0.01), cutaneous lesions (47% vs. 68%, p=0.001), including pseudofolliculitis (34% vs. 53%, p=0.001) and erythema nodosum (24% vs. 36%, p=0.03), uveitis (32% vs. 44%, p=0.03), corticosteroids (68% vs. 88%, p < 0.001), azathioprine (56% vs. 70%, p=0.01), cyclosporine (9% vs. 22%, p=0.004), cyclophosphamide (19% vs. 34%, p=0.001), and intravenous immunoglobulin use (9% vs. 18%, p=0.03) were significantly lower in the former group. Frequencies of oral and cutaneous ulcers, articular or central nervous system involvement, retinal vasculitis, colchicine, mycophenolate mofetil, and methotrexate use were similar in both groups (p >0.05).

Conclusion: cBS was rarely observed in our non-endemic region, potentially due to under recognition, as it often presented with nonspecific symptoms such as fever and gastrointestinal involvement. The broader spectrum of symptoms in aBS patients might account for the more extensive use of immunosuppressive agents.


Disclosures: R. Machado: None; T. Souza: None; M. França: None; V. Matias: None; S. Farhat: None; C. Siqueira: None; M. Santos: None; L. Steuer: None; L. Forero: None; R. Bassara Macedo: None; T. Freitas: None; b. Bayeh: None; C. Ejnisman: None; P. Araujo: None; R. Cordeiro: None; F. Specian: None; V. Balbi: None; N. Aikawa: Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP) (2022/12925-8), 5, GlaxoSmithKlein(GSK), 5; K. Kozu: None; C. Silva: Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) (304984/2020-5), 5, Fundação de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (2022/12925-8), 5, GlaxoSmithKlein(GSK), 5; L. Campos: None; A. Elias: None; H. Giardini: None.

To cite this abstract in AMA style:

Machado R, Souza T, França M, Matias V, Farhat S, Siqueira C, Santos M, Steuer L, Forero L, Bassara Macedo R, Freitas T, Bayeh b, Ejnisman C, Araujo P, Cordeiro R, Specian F, Balbi V, Aikawa N, Kozu K, Silva C, Campos L, Elias A, Giardini H. Behçet’s syndrome: distinct features in 344 pediatric and adult patients in a non-endemic region [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/behcets-syndrome-distinct-features-in-344-pediatric-and-adult-patients-in-a-non-endemic-region/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/behcets-syndrome-distinct-features-in-344-pediatric-and-adult-patients-in-a-non-endemic-region/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology